ジェネリック医薬品有効成分の世界市場（～2026年）

• 英文タイトル：Global Generic Active Pharmaceutical Ingredients Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY06747
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、118ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はジェネリック医薬品有効成分のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子）市場規模、用途別（腫瘍学、糖尿病、心血管疾患、CNS・神経障害、内分泌学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ジェネリック医薬品有効成分の競争状況、市場シェア
・世界のジェネリック医薬品有効成分市場：種類別市場規模 2015年-2020年（モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子）
・世界のジェネリック医薬品有効成分市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子）
・世界のジェネリック医薬品有効成分市場：用途別市場規模 2015年-2020年（腫瘍学、糖尿病、心血管疾患、CNS・神経障害、内分泌学、その他）
・世界のジェネリック医薬品有効成分市場：用途別市場規模予測 2021年-2026年（腫瘍学、糖尿病、心血管疾患、CNS・神経障害、内分泌学、その他）
・北米のジェネリック医薬品有効成分市場分析：米国、カナダ
・ヨーロッパのジェネリック医薬品有効成分市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのジェネリック医薬品有効成分市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のジェネリック医薬品有効成分市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのジェネリック医薬品有効成分市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer, Inc. (U.S.)、Novartis International AG (Switzerland)、Sanofi (France)、Boehringer Ingelheim (Germany)、Bristol-Myers Squibb (U.S.)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (U.S.)、GlaxoSmithKline plc (U.K.)、Merck & Co., Inc. (U.S.)、AbbVie Inc. (U.S.)
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Generic Active Pharmaceutical Ingredients Market
The global Generic Active Pharmaceutical Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Generic Active Pharmaceutical Ingredients Scope and Market Size
Generic Active Pharmaceutical Ingredients market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Generic Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Generic Active Pharmaceutical Ingredients market is segmented into
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors

Segment by Application, the Generic Active Pharmaceutical Ingredients market is segmented into
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others

Regional and Country-level Analysis
The Generic Active Pharmaceutical Ingredients market is analysed and market size information is provided by regions (countries).
The key regions covered in the Generic Active Pharmaceutical Ingredients market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Generic Active Pharmaceutical Ingredients Market Share Analysis
Generic Active Pharmaceutical Ingredients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Generic Active Pharmaceutical Ingredients business, the date to enter into the Generic Active Pharmaceutical Ingredients market, Generic Active Pharmaceutical Ingredients product introduction, recent developments, etc.

The major vendors covered:
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)

レポート目次

1 Study Coverage
1.1 Generic Active Pharmaceutical Ingredients Product Introduction
1.2 Market Segments
1.3 Key Generic Active Pharmaceutical Ingredients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Hormones
1.4.4 Cytokines
1.4.5 Fusion Proteins
1.4.6 Therapeutic Enzymes
1.4.7 Vaccines
1.4.8 Blood Factors
1.5 Market by Application
1.5.1 Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Disease
1.5.5 CNS and Neurological Disorders
1.5.6 Endocrinology
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Generic Active Pharmaceutical Ingredients Market Size, Estimates and Forecasts
2.1.1 Global Generic Active Pharmaceutical Ingredients Revenue 2015-2026
2.1.2 Global Generic Active Pharmaceutical Ingredients Sales 2015-2026
2.2 Global Generic Active Pharmaceutical Ingredients, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Generic Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Generic Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Generic Active Pharmaceutical Ingredients Competitor Landscape by Players
3.1 Generic Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.1 Generic Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020)
3.1.2 Generic Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)
3.2 Generic Active Pharmaceutical Ingredients Revenue by Manufacturers
3.2.1 Generic Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020)
3.2.2 Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Generic Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Generic Active Pharmaceutical Ingredients Revenue in 2019
3.2.5 Global Generic Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Generic Active Pharmaceutical Ingredients Price by Manufacturers
3.4 Generic Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
3.4.1 Generic Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Generic Active Pharmaceutical Ingredients Product Type
3.4.3 Date of International Manufacturers Enter into Generic Active Pharmaceutical Ingredients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Generic Active Pharmaceutical Ingredients Market Size by Type (2015-2020)
4.1.1 Global Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020)
4.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Type (2015-2020)
4.1.3 Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Generic Active Pharmaceutical Ingredients Market Size Forecast by Type (2021-2026)
4.2.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026)
4.2.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026)
4.2.3 Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Generic Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Generic Active Pharmaceutical Ingredients Market Size by Application (2015-2020)
5.1.1 Global Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020)
5.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Application (2015-2020)
5.1.3 Generic Active Pharmaceutical Ingredients Price by Application (2015-2020)
5.2 Generic Active Pharmaceutical Ingredients Market Size Forecast by Application (2021-2026)
5.2.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026)
5.2.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026)
5.2.3 Global Generic Active Pharmaceutical Ingredients Price Forecast by Application (2021-2026)

6 North America
6.1 North America Generic Active Pharmaceutical Ingredients by Country
6.1.1 North America Generic Active Pharmaceutical Ingredients Sales by Country
6.1.2 North America Generic Active Pharmaceutical Ingredients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
6.3 North America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

7 Europe
7.1 Europe Generic Active Pharmaceutical Ingredients by Country
7.1.1 Europe Generic Active Pharmaceutical Ingredients Sales by Country
7.1.2 Europe Generic Active Pharmaceutical Ingredients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
7.3 Europe Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Generic Active Pharmaceutical Ingredients by Region
8.1.1 Asia Pacific Generic Active Pharmaceutical Ingredients Sales by Region
8.1.2 Asia Pacific Generic Active Pharmaceutical Ingredients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
8.3 Asia Pacific Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

9 Latin America
9.1 Latin America Generic Active Pharmaceutical Ingredients by Country
9.1.1 Latin America Generic Active Pharmaceutical Ingredients Sales by Country
9.1.2 Latin America Generic Active Pharmaceutical Ingredients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
9.3 Central & South America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Generic Active Pharmaceutical Ingredients by Country
10.1.1 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country
10.1.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
10.3 Middle East and Africa Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer, Inc. (U.S.)
11.1.1 Pfizer, Inc. (U.S.) Corporation Information
11.1.2 Pfizer, Inc. (U.S.) Description and Business Overview
11.1.3 Pfizer, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.1.5 Pfizer, Inc. (U.S.) Related Developments
11.2 Novartis International AG (Switzerland)
11.2.1 Novartis International AG (Switzerland) Corporation Information
11.2.2 Novartis International AG (Switzerland) Description and Business Overview
11.2.3 Novartis International AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Products Offered
11.2.5 Novartis International AG (Switzerland) Related Developments
11.3 Sanofi (France)
11.3.1 Sanofi (France) Corporation Information
11.3.2 Sanofi (France) Description and Business Overview
11.3.3 Sanofi (France) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi (France) Generic Active Pharmaceutical Ingredients Products Offered
11.3.5 Sanofi (France) Related Developments
11.4 Boehringer Ingelheim (Germany)
11.4.1 Boehringer Ingelheim (Germany) Corporation Information
11.4.2 Boehringer Ingelheim (Germany) Description and Business Overview
11.4.3 Boehringer Ingelheim (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Products Offered
11.4.5 Boehringer Ingelheim (Germany) Related Developments
11.5 Bristol-Myers Squibb (U.S.)
11.5.1 Bristol-Myers Squibb (U.S.) Corporation Information
11.5.2 Bristol-Myers Squibb (U.S.) Description and Business Overview
11.5.3 Bristol-Myers Squibb (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.5.5 Bristol-Myers Squibb (U.S.) Related Developments
11.6 Teva Pharmaceutical Industries Ltd. (Israel)
11.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Products Offered
11.6.5 Teva Pharmaceutical Industries Ltd. (Israel) Related Developments
11.7 Eli Lilly and Company (U.S.)
11.7.1 Eli Lilly and Company (U.S.) Corporation Information
11.7.2 Eli Lilly and Company (U.S.) Description and Business Overview
11.7.3 Eli Lilly and Company (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.7.5 Eli Lilly and Company (U.S.) Related Developments
11.8 GlaxoSmithKline plc (U.K.)
11.8.1 GlaxoSmithKline plc (U.K.) Corporation Information
11.8.2 GlaxoSmithKline plc (U.K.) Description and Business Overview
11.8.3 GlaxoSmithKline plc (U.K.) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Products Offered
11.8.5 GlaxoSmithKline plc (U.K.) Related Developments
11.9 Merck & Co., Inc. (U.S.)
11.9.1 Merck & Co., Inc. (U.S.) Corporation Information
11.9.2 Merck & Co., Inc. (U.S.) Description and Business Overview
11.9.3 Merck & Co., Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.9.5 Merck & Co., Inc. (U.S.) Related Developments
11.10 AbbVie Inc. (U.S.)
11.10.1 AbbVie Inc. (U.S.) Corporation Information
11.10.2 AbbVie Inc. (U.S.) Description and Business Overview
11.10.3 AbbVie Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.10.5 AbbVie Inc. (U.S.) Related Developments
11.1 Pfizer, Inc. (U.S.)
11.1.1 Pfizer, Inc. (U.S.) Corporation Information
11.1.2 Pfizer, Inc. (U.S.) Description and Business Overview
11.1.3 Pfizer, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.1.5 Pfizer, Inc. (U.S.) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Generic Active Pharmaceutical Ingredients Market Estimates and Projections by Region
12.1.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Regions 2021-2026
12.1.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Regions 2021-2026
12.2 North America Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.2.1 North America: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.2.2 North America: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.2.3 North America: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.3 Europe Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.3.1 Europe: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.3.2 Europe: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.3.3 Europe: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Generic Active Pharmaceutical Ingredients Market Size Forecast by Region (2021-2026)
12.5 Latin America Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.5.1 Latin America: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.5.2 Latin America: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.5.3 Latin America: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Generic Active Pharmaceutical Ingredients Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Generic Active Pharmaceutical Ingredients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Generic Active Pharmaceutical Ingredients Market Segments
Table 2. Ranking of Global Top Generic Active Pharmaceutical Ingredients Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Hormones
Table 6. Major Manufacturers of Cytokines
Table 7. Major Manufacturers of Fusion Proteins
Table 8. Major Manufacturers of Therapeutic Enzymes
Table 9. Major Manufacturers of Vaccines
Table 10. Major Manufacturers of Blood Factors
Table 11. Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Generic Active Pharmaceutical Ingredients Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Generic Active Pharmaceutical Ingredients Sales by Regions 2015-2020 (K MT)
Table 14. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Regions (2015-2020)
Table 15. Global Generic Active Pharmaceutical Ingredients Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Generic Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Generic Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015-2020)
Table 18. Global Generic Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Generic Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Active Pharmaceutical Ingredients as of 2019)
Table 20. Generic Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Generic Active Pharmaceutical Ingredients Price (2015-2020) (USD/MT)
Table 23. Generic Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Generic Active Pharmaceutical Ingredients Product Type
Table 25. Date of International Manufacturers Enter into Generic Active Pharmaceutical Ingredients Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 28. Global Generic Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)
Table 29. Global Generic Active Pharmaceutical Ingredients Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Generic Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)
Table 31. Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 33. Global Generic Active Pharmaceutical Ingredients Sales Share by Application (2015-2020)
Table 34. North America Generic Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 35. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 36. North America Generic Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 38. North America Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 39. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 40. North America Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 41. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 42. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 43. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 44. Europe Generic Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 46. Europe Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 47. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 48. Europe Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 49. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 58. Latin America Generic Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 59. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Generic Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 62. Latin America Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 63. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 64. Latin America Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 65. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 74. Pfizer, Inc. (U.S.) Corporation Information
Table 75. Pfizer, Inc. (U.S.) Description and Major Businesses
Table 76. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Pfizer, Inc. (U.S.) Product
Table 78. Pfizer, Inc. (U.S.) Recent Development
Table 79. Novartis International AG (Switzerland) Corporation Information
Table 80. Novartis International AG (Switzerland) Description and Major Businesses
Table 81. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis International AG (Switzerland) Product
Table 83. Novartis International AG (Switzerland) Recent Development
Table 84. Sanofi (France) Corporation Information
Table 85. Sanofi (France) Description and Major Businesses
Table 86. Sanofi (France) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Sanofi (France) Product
Table 88. Sanofi (France) Recent Development
Table 89. Boehringer Ingelheim (Germany) Corporation Information
Table 90. Boehringer Ingelheim (Germany) Description and Major Businesses
Table 91. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Boehringer Ingelheim (Germany) Product
Table 93. Boehringer Ingelheim (Germany) Recent Development
Table 94. Bristol-Myers Squibb (U.S.) Corporation Information
Table 95. Bristol-Myers Squibb (U.S.) Description and Major Businesses
Table 96. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Bristol-Myers Squibb (U.S.) Product
Table 98. Bristol-Myers Squibb (U.S.) Recent Development
Table 99. Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
Table 100. Teva Pharmaceutical Industries Ltd. (Israel) Description and Major Businesses
Table 101. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Teva Pharmaceutical Industries Ltd. (Israel) Product
Table 103. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 104. Eli Lilly and Company (U.S.) Corporation Information
Table 105. Eli Lilly and Company (U.S.) Description and Major Businesses
Table 106. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Eli Lilly and Company (U.S.) Product
Table 108. Eli Lilly and Company (U.S.) Recent Development
Table 109. GlaxoSmithKline plc (U.K.) Corporation Information
Table 110. GlaxoSmithKline plc (U.K.) Description and Major Businesses
Table 111. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline plc (U.K.) Product
Table 113. GlaxoSmithKline plc (U.K.) Recent Development
Table 114. Merck & Co., Inc. (U.S.) Corporation Information
Table 115. Merck & Co., Inc. (U.S.) Description and Major Businesses
Table 116. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Merck & Co., Inc. (U.S.) Product
Table 118. Merck & Co., Inc. (U.S.) Recent Development
Table 119. AbbVie Inc. (U.S.) Corporation Information
Table 120. AbbVie Inc. (U.S.) Description and Major Businesses
Table 121. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. AbbVie Inc. (U.S.) Product
Table 123. AbbVie Inc. (U.S.) Recent Development
Table 124. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Regions (2021-2026) (K MT)
Table 125. Global Generic Active Pharmaceutical Ingredients Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Generic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Generic Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 129. North America: Generic Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Generic Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 131. Europe: Generic Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Generic Active Pharmaceutical Ingredients Sales Forecast by Region (2021-2026) (K MT)
Table 133. Asia Pacific: Generic Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Generic Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 135. Latin America: Generic Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Generic Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 137. Middle East and Africa: Generic Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Generic Active Pharmaceutical Ingredients Players
Table 142. Generic Active Pharmaceutical Ingredients Customers List
Table 143. Generic Active Pharmaceutical Ingredients Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Active Pharmaceutical Ingredients Product Picture
Figure 2. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Hormones Product Picture
Figure 5. Cytokines Product Picture
Figure 6. Fusion Proteins Product Picture
Figure 7. Therapeutic Enzymes Product Picture
Figure 8. Vaccines Product Picture
Figure 9. Blood Factors Product Picture
Figure 10. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020 & 2026
Figure 11. Oncology
Figure 12. Diabetes
Figure 13. Cardiovascular Disease
Figure 14. CNS and Neurological Disorders
Figure 15. Endocrinology
Figure 16. Others
Figure 17. Generic Active Pharmaceutical Ingredients Report Years Considered
Figure 18. Global Generic Active Pharmaceutical Ingredients Market Size 2015-2026 (US$ Million)
Figure 19. Global Generic Active Pharmaceutical Ingredients Sales 2015-2026 (K MT)
Figure 20. Global Generic Active Pharmaceutical Ingredients Market Size Market Share by Region: 2020 Versus 2026
Figure 21. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Figure 22. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 23. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Figure 24. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 25. Global Generic Active Pharmaceutical Ingredients Sales Share by Manufacturer in 2019
Figure 26. The Top 10 and 5 Players Market Share by Generic Active Pharmaceutical Ingredients Revenue in 2019
Figure 27. Generic Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Figure 29. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 30. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type (2015-2020)
Figure 31. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type in 2019
Figure 32. Global Generic Active Pharmaceutical Ingredients Market Share by Price Range (2015-2020)
Figure 33. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Figure 34. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 35. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)
Figure 36. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application in 2019
Figure 37. North America Generic Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 38. North America Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 40. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 41. U.S. Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 42. U.S. Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 44. Canada Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. North America Generic Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 46. North America Generic Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 47. Europe Generic Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 48. Europe Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 50. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 51. Germany Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 52. Germany Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 54. France Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 56. U.K. Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 58. Italy Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 60. Russia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Europe Generic Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 62. Europe Generic Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 63. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 64. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 66. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 67. China Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 68. China Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 70. Japan Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 72. South Korea Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 74. India Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 76. Australia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 78. Taiwan Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 80. Indonesia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 82. Thailand Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 84. Malaysia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 86. Philippines Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 88. Vietnam Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Asia Pacific Generic Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 90. Asia Pacific Generic Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 91. Latin America Generic Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 92. Latin America Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 93. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 94. Latin America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 95. Mexico Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 96. Mexico Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Brazil Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 98. Brazil Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Argentina Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 100. Argentina Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Latin America Generic Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 102. Latin America Generic Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 103. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 104. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 105. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 106. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 107. Turkey Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 108. Turkey Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Saudi Arabia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 110. Saudi Arabia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. U.A.E Generic Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 112. U.A.E Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 113. Middle East and Africa Generic Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 114. Middle East and Africa Generic Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 115. North America Generic Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. North America Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Generic Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Europe Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Generic Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Latin America Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed

以下、関連資料のご紹介

高薬理活性原薬 (HPAPI)の世界市場（～2026年）

Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size, Status and Forecast 2020-2026
MRC2-11QY12187 2020年11月25日 98Pages
当調査資料は高薬理活性原薬 (HPAPI)のグローバル市場について調査・分析したレポートです。種類別（合成HPAPI、バイオテクノロジーHPAPI）市場規模、用途別（中枢神経系障害、腫瘍学、ホルモン障害、緑内障、感染症、代謝障害、心血管、炎症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

HPAPI（高力価有効成分）の世界市場（～2026年）

Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Insights and Forecast to 2026
MRC2-11QY01411 2020年11月20日 111Pages
当調査資料はHPAPI（高力価有効成分）のグローバル市場について調査・分析したレポートです。種類別（革新的HPAPI、汎用HPAPI）市場規模、用途別（キャプティブHPAPI、マーチャントHPAPI）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

高性能医薬品有効成分（HPAPI）の世界市場（～2026年）

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Insights and Forecast to 2026
MRC2-11QY01193 2020年11月20日 112Pages
当調査資料は高性能医薬品有効成分（HPAPI）のグローバル市場について調査・分析したレポートです。種類別（合成成分、生物成分、その他）市場規模、用途別（腫瘍学、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

高力価医薬品有効成分（API）の世界市場（～2026年）

Global High Potency Active Pharmaceutical Ingredients (APIs) Market Insights and Forecast to 2026
MRC2-11QY01212 2020年11月20日 154Pages
当調査資料は高力価医薬品有効成分（API）のグローバル市場について調査・分析したレポートです。種類別（合成、バイオテクノロジー）市場規模、用途別（腫瘍学、ホルモン、緑内障、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

医薬品有効成分の世界市場（～2026年）

Global Active Pharma Ingredient Market Insights and Forecast to 2026
MRC2-11QY02082 2020年11月20日 183Pages
当調査資料は医薬品有効成分のグローバル市場について調査・分析したレポートです。種類別（革新的医薬品有効成分、ジェネリック医薬品有効成分）市場規模、用途別（腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

ジェネリック注射剤の世界市場（～2026年）

Global Generic Injectables Market Insights and Forecast to 2026
MRC2-11QY06748 2020年11月20日 114Pages
当調査資料はジェネリック注射剤のグローバル市場について調査・分析したレポートです。種類別（大分子注射剤（バイオシミラー）、小分子注射剤）市場規模、用途別（腫瘍学、感染症、心臓病学、糖尿病、免疫学）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

インスリン有効成分の世界市場（～2026年）

Global Insulin Active Pharmaceutical Ingredient Market Insights and Forecast to 2026
MRC2-11QY01752 2020年11月20日 110Pages
当調査資料はインスリン有効成分のグローバル市場について調査・分析したレポートです。種類別（化学合成、動物抽出物）市場規模、用途別（動物インスリン、通常ヒトインスリン、インスリンアナログ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

パーソナルケア用有効成分の世界市場（～2026年）

Global Active Ingredients in Personal Care Market Insights and Forecast to 2026
MRC2-11QY02078 2020年11月20日 149Pages
当調査資料はパーソナルケア用有効成分のグローバル市場について調査・分析したレポートです。種類別（天然、合成）市場規模、用途別（スキンケア、ヘアケア、オーラルケア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

動物用ジェネリック医薬品の世界市場（～2026年）

Global Animal Generic Drug Market Insights and Forecast to 2026
MRC2-11QY02466 2020年11月20日 118Pages
当調査資料は動物用ジェネリック医薬品のグローバル市場について調査・分析したレポートです。種類別（医薬品、生物製剤、医薬品添加物）市場規模、用途別（ブロイラー、豚、牛、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

吸入・点鼻薬ジェネリック医薬品の世界市場（～2026年）

Global Inhalation and Nasal Spray Generic Drugs Market Insights and Forecast to 2026
MRC2-11QY01683 2020年11月20日 115Pages
当調査資料は吸入・点鼻薬ジェネリック医薬品のグローバル市場について調査・分析したレポートです。種類別（コルチコステロイド、気管支拡張薬、混合、充血除去スプレー、その他）市場規模、用途別（喘息、COPD、アレルギー性鼻炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

HPAPI（高力価有効成分）の世界市場（～2026年） Market Analysis and Insights: Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market The global HPAPI (High Potency Active Pharmaceutical Ingredients) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global HPAPI…
高薬理活性原薬 (HPAPI)の世界市場（～2026年） The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) = 10µg/m3. Market Analysis and Insights: Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market The global High Potency Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX m…
高性能医薬品有効成分（HPAPI）の世界市場（～2026年） Market Analysis and Insights: Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market The global High Performance Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Glob…
高力価医薬品有効成分（API）の世界市場（～2026年） High Potency Active Pharmaceutical Ingredients (APIs) have higher active level targeting sever diseases such as tumour cells, infected cells, damaged organs than regular medicine elements. Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compounds. …
ジェネリック注射剤の世界市場（～2026年） Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Market Analysis and Insights: Global Generic Injectabl…